The ALL frontier: should T-ALL be classed as a different disease?

Speaking from the 2018 European School of Hematology (ESH) Clinical Updates on Acute Leukemias, Elizabeth Macintyre, MD, PhD, of the Hpital Necker-Enfants Malades, Paris, France, explains why she bel... Author: VJHemOnc Added: 08/13/2018
Source: Oncology Tube - Category: Cancer & Oncology Source Type: podcasts